Walder Ventures is a Chicago-based venture capital firm established in 2020, dedicated to mission-driven investments aimed at fostering the vibrancy and sustainability of the Chicago region and beyond. The firm focuses on early-stage life science companies, seeking to support innovative ventures that contribute positively to the community and the economy. By concentrating on impactful investments, Walder Ventures aims to enhance the overall quality of life in the areas it serves while promoting growth within the life sciences sector.
Grove Biopharma is a biotechnology company dedicated to addressing unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases. It specializes in the discovery and development of a new class of protein-like polymers, utilizing artificial intelligence and precision polymer chemistry to create hybrid synthetic protein mimetics. The company also provides materials science solutions to tackle challenges associated with peptide therapeutics, thereby facilitating researchers' access to innovative drugs in critical areas of healthcare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.